Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

NCT01735006 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7372

Enrollment

OTHER

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia
Cervical Cancer
Vaginal Intraepithelial Neoplasia
Vulvar Intraepithelial Neoplasia
Persistent Infection

Interventions

BIOLOGICAL: HPV Vaccine
BIOLOGICAL: HEV vaccine

Sponsor

Xiamen University

Collaborators

[object Object]
[object Object]
[object Object]